Analyst Activity – Cann Reiterates Hold on Editas Medicine (NASDAQ:EDIT)

ME Staff
-
0

Analyst Ratings For Editas Medicine (NASDAQ:EDIT)

Today, Cann reiterated its Hold rating on Editas Medicine (NASDAQ:EDIT).

Some recent analyst ratings include

  • 2/16/2018-Cann Reiterated Rating of Hold.
  • 2/13/2018-CLSA initiated coverage with a Underperform rating.
  • 1/23/2018-SunTrust Banks Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 11/7/2017-Cowen Reiterated Rating of Buy.
  • 10/6/2017-Morgan Stanley Reiterated Rating of Equal Weight.
  • 9/6/2017-Barclays initiated coverage with a Overweight rating.

Recent Insider Trading Activity For Editas Medicine (NASDAQ:EDIT)
Editas Medicine (NASDAQ:EDIT) has insider ownership of 19.40% and institutional ownership of 64.52%.

  • On 2/1/2018 Katrine Bosley, CEO, sold 8,333 with an average share price of $36.18 per share and the total transaction amounting to $301,487.94.
  • On 1/30/2018 Katrine Bosley, Insider, sold 20,000 with an average share price of $38.79 per share and the total transaction amounting to $775,800.00.
  • On 1/23/2018 Katrine Bosley, Insider, sold 3,338 with an average share price of $35.28 per share and the total transaction amounting to $117,764.64.
  • On 1/3/2018 Katrine Bosley, Insider, sold 14,995 with an average share price of $34.15 per share and the total transaction amounting to $512,079.25.
  • On 12/19/2017 Andrew A F Hack, CFO, sold 14,649 with an average share price of $24.68 per share and the total transaction amounting to $361,537.32.
  • On 12/15/2017 Andrew A F Hack, CFO, sold 5,000 with an average share price of $24.31 per share and the total transaction amounting to $121,550.00.
  • On 12/1/2017 Katrine Bosley, Insider, sold 8,333 with an average share price of $29.58 per share and the total transaction amounting to $246,490.14.

Recent Trading Activity for Editas Medicine (NASDAQ:EDIT)
Shares of Editas Medicine closed the previous trading session at 35.38 up +0.59 1.69% with 636703 shares trading hands.